Biosimilars Market is Expected to Grow at a CAGR of 26% from 2016 to 2023

Biosimilars Market is Expected to Grow at a CAGR of 26% from 2016 to 2023


Major key Players include Pfizer Inc,Teva Pharmaceuticals Industries Ltd,Sandoz International GmbH,Celltrion, Inc,Astra Zeneca,Amgen Inc.,F. Hoffmann-La Roche Ltd." PUNE, MAHARASHTRA, INDIA, July 7, 2017 / EINPresswire.com / -- Market Highlights Biosimilars also known as follow-on biologic or subsequent entry biologics which are biological medical products.



from Biotech News